Boron-containing small molecules
US-2015119364-A1 · Apr 30, 2015 · US
Boron-containing small molecules
US9549938B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9549938-B2 |
| Application number | US-201615068352-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 11, 2016 |
| Priority date | Feb 16, 2005 |
| Publication date | Jan 24, 2017 |
| Grant date | Jan 24, 2017 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
This invention relates to compounds useful for treating fungal infections, more specifically topical treatment of onychomycosis and/or cutaneous fungal infections. This invention is directed to compounds that are active against fungi and have properties that allow the compound, when placed in contact with a patient, to reach the particular part of the skin, nail, hair, claw or hoof infected by the fungus. In particular the present compounds have physiochemical properties that facilitate penetration of the nail plate.
First claim
Opening claim text (preview).
What is claimed is: 1. A method of treating a Tinea unguium infection of a toenail of a human, the method comprising: topically administering to the toenail of the human a pharmaceutical composition comprising 1,3-dihydro-5-fluoro-1-hydroxy-2,1-benzoxaborole or a pharmaceutically acceptable salt thereof in an amount sufficient to treat the infection. 2. The method of claim 1 , wherein the Tinea unguium infection is due to Trichophyton rubrum or Trichophyton mentagrophytes. 3. The method of claim 1 , wherein the pharmaceutical composition is in the form of a solution comprising 5% w/w of 1,3-dihydro-5-fluoro-1-hydroxy-2,1-benzoxaborole. 4. The method of claim 1 , wherein the pharmaceutical composition further comprises ethanol and propylene glycol. 5. The method of claim 1 , wherein the Tinea unguium infection is due to Trichophyton rubrum or Trichophyton mentagrophytes , and wherein the pharmaceutical composition is in the form of a solution comprising 5% w/w of 1,3-dihydro-5-fluoro-1-hydroxy-2,1-benzoxaborole. 6. The method of claim 5 , wherein the pharmaceutical composition further comprises ethanol and propylene glycol.
Assignees
Inventors
Classifications
Antimycotics · CPC title
Purine radicals · CPC title
Compounds containing boron, silicon or a metal, e.g. chelates or vitamin B12 (esters with inorganic acids C07H11/00) · CPC title
- C07F5/025Primary
Boronic and borinic acid compounds · CPC title
Solutions {(composition of solutions A61K47/00)} · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9549938B2 cover?
- This invention relates to compounds useful for treating fungal infections, more specifically topical treatment of onychomycosis and/or cutaneous fungal infections. This invention is directed to compounds that are active against fungi and have properties that allow the compound, when placed in contact with a patient, to reach the particular part of the skin, nail, hair, claw or hoof infected by …
- Who is the assignee on this patent?
- Anacor Pharmaceuticals Inc
- What technology area does this patent fall under?
- Primary CPC classification C07F5/025. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).